Triangle Business JournalPfizer takes big gene therapy step after acquisition in Chapel HillTriangle Business JournalThe new trial underway is a Phase 1b clinical trial for a gene therapy candidate for the treatment of boys with Duchenne muscular dystr… Continue reading
Protagen Shifting to Focus on Cancer ImmunotherapyGenomeWebNEW YORK (GenomeWeb) – With a series of recent collaborations, German biomarker firm Protagen is shifting its focus to cancer immunotherapy. Over the last year the company has signed agreements… Continue reading
Cancer Therapy AdvisorRotavirus Vaccine May Overcome Immunotherapy ResistanceCancer Therapy AdvisorA rotavirus vaccine may help to overcome resistance to immune checkpoint inhibitors used in patients with cancer, according to findings being presented a… Continue reading
Gene Therapy in Community Practices—Administering CAR-T TherapiesAJMC.com Managed Markets NetworkSurabhi Dangi-Garimella, PhD. How are community practices coping with administering chimeric antigen receptor (CAR)-T treatments? At the 2018 Community Onc… Continue reading
Prescribed Reading: Novartis ups the ante in gene therapy, while GSK folds on the spaceBioPharma DiveThe M&A bonanza of 2018 continued in earnest this week, with Novartis AG plopping down more than $8 billion for a gene therapy company and Alexion … Continue reading
Health Thoroughfare |
We’re about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are …
Business Insider On Monday, three big players in the growing field of cancer immunotherapy are sharing data that could change how we treat lung cancer. The three companies, Bristol-Myers Squibb, Merck, and Roche, are looking at how their immunotherapies, known as … Immunotherapy, a Wonder for the Lung Cancer PatientsHealth Thoroughfare EGFR+ NSCLC: Treatment Through Multiple Lines of TherapyTargeted Oncology |
Health Thoroughfare |
We’re about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are …
Business Insider On Monday, three big players in the growing field of cancer immunotherapy are sharing data that could change how we treat lung cancer. The three companies, Bristol-Myers Squibb, Merck, and Roche, are looking at how their immunotherapies, known as … Immunotherapy, a Wonder for the Lung Cancer PatientsHealth Thoroughfare EGFR+ NSCLC: Treatment Through Multiple Lines of TherapyTargeted Oncology |